mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |
mRNA |
Vorinostat |
FIMM |
pan-cancer |
AAC |
0.25 |
0.1 |
mRNA |
Roscovitine |
FIMM |
pan-cancer |
AAC |
0.26 |
0.1 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.1 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.078 |
0.1 |